Target intelligence / Profile preview

Leucine-rich repeat-containing protein 70 (LRRC70)

Target
LRRC70
Molecular classification
Other (Leucine-rich repeat family protein), Leucine-rich repeat protein (not classified as receptor, enzyme, transporter, ion channel, or transcription factor)
01

Overview

Leucine-rich repeat-containing protein 70 (LRRC70) is a human protein encoded by the LRRC70 gene, located on chromosome 5q12.1[4][10]. It belongs to the large family of leucine-rich repeat (LRR) proteins, which are commonly involved in diverse cellular processes, including innate immunity, cell signaling, and structural roles. LRRC70 renders cells more sensitive to activation by cytokines and lipopolysaccharide (LPS), suggesting a role—possibly indirect—in immune regulation[1][7]. However, unlike other well-characterized LRR proteins, LRRC70 lacks definitive functional annotation, identifiable non-LRR domains, and a clear mechanistic or disease linkage[2][5]. It is mainly classified as a leucine-rich repeat family protein and not as a receptor, enzyme, transporter, or transcription factor. The protein has low tissue specificity and is currently not recognized as a therapeutic target or clinical biomarker[3][7]. Most functions and disease associations remain speculative, inferred from protein family similarity or gene coexpression, rather than direct experimental evidence.

Other names
SLRNSynleurinLOC100130733UNQ1891/PRO4337Leucine rich repeat containing 70LRRC70Leucine-rich repeat-containing protein 70synleurin
02

Mechanism of action

None known (no mechanism described for drugs targeting LRRC70, as it is not an established drug target)

03

Biological functions

Positive regulation of response to cytokine stimulusRenders cells highly sensitive to activation by cytokines and lipopolysaccharide (LPS)Putative role in innate immunity, autophagy, or cell structure (inferred from function of LRR proteins generally, but not specifically confirmed for LRRC70)Other (Function largely uncharacterized)
04

Disease associations

Lymphocytic colitisNight blindness, congenital stationary, type 1A (association only—not evidence for causality or direct mechanistic role)Other (no definitive disease associations known, potential link to immune or inflammatory pathways inferred from protein family)

Beyond the preview

Go deeper on Leucine-rich repeat-containing protein 70 (LRRC70).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat-containing protein 70 (LRRC70).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call